Generic placeholder image

Current Medicinal Chemistry


ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

Hybrid Imidazole-Pyridine Derivatives: An Approach to Novel Anticancer DNA Intercalators

Author(s): Claudiu N. Lungu*, Bogdan Ionel Bratanovici , Maria Mirabela Grigore, Vasilichia Antoci and Ionel I. Mangalagiu*

Volume 27, Issue 1, 2020

Page: [154 - 169] Pages: 16

DOI: 10.2174/0929867326666181220094229

Price: $65


Lack of specificity and subsequent therapeutic effectiveness of antimicrobial and antitumoral drugs is a common difficulty in therapy. The aim of this study is to investigate, both by experimental and computational methods, the antitumoral and antimicrobial properties of a series of synthesized imidazole-pyridine derivatives. Interaction with three targets was discussed: Dickerson-Drew dodecamer (PDB id 2ADU), G-quadruplex DNA string (PDB id 2F8U) and DNA strain in complex with dioxygenase (PDB id 3S5A). Docking energies were computed and represented graphically. On them, a QSAR model was developed in order to further investigate the structure-activity relationship. Results showed that synthesized compounds have antitumoral and antimicrobial properties. Computational results agreed with the experimental data.

Keywords: Anticancer drugs, DNA intercalators, docking, binding site, hybrid imidazole-pyridine derivatives, QSAR model.

Richaud, A.; Barba-Behrens, N.; Méndez, F. Chemical reactivity of the imidazole: a semblance of pyridine and pyrrole? Org. Lett., 2011, 13(5), 972-975.
[] [PMID: 21268606]
Zhang, L.; Peng, X.M.; Damu, G.L.; Geng, R.X.; Zhou, C.H. Comprehensive review in current developments of imidazole-based medicinal chemistry. Med. Res. Rev., 2014, 34(2), 340-437.
[] [PMID: 23740514]
Neidle, S.; Pearl, L.H.; Herzyk, P.; Berman, H.M. A molecular model for proflavine-DNA intercalation. Nucleic Acids Res., 1988, 16(18), 8999-9016.
[] [PMID: 3174439]
Richards, A.D.; Rodger, A. Synthetic metallomolecules as agents for the control of DNA structure. Chem. Soc. Rev., 2007, 36(3), 471-483.
[] [PMID: 17325786]
Luzzati, V.; Masson, F.; Lerman, L.S. Interaction of DNA and proflavine: a small-angle x-ray scattering study. J. Mol. Biol., 1961, 3(5), 634-639.
[] [PMID: 14467543]
Gai, D.; Chang, Y.P.; Chen, X.S. Origin DNA melting and unwinding in DNA replication. Curr. Opin. Struct. Biol., 2010, 20(6), 756-762.
[] [PMID: 20870402]
Morávek, Z.; Neidle, S.; Schneider, B. Protein and drug interactions in the minor groove of DNA. Nucleic Acids Res., 2002, 30(5), 1182-1191.
[] [PMID: 11861910]
Hall, D.R.; Kozakov, D.; Whitty, A.; Vajda, S. Lessons from hot spot analysis for fragment-based drug discovery. Trends Pharmacol. Sci., 2015, 36(11), 724-736.
[] [PMID: 26538314]
Dorina, M.; Vasilichia, A.; Costel, M.; Gheorghita, Z. Ionel, I., Mangalagiu. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity. J. Enzyme Inhib. Med. Chem., 2016, 31(2), 96-103.
[] [PMID: 27250919]
Shoemaker, R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer, 2006, 6(10), 813-823.
[] [PMID: 16990858]
National Cancer Instituite. Developmental Therapeutics Program, Available at:. November 17, 2017
Tereshko, V.; Minasov, G.; Egli, M. The Dickerson-Drew B-DNADodecamer Revisited-AtAtomic Resolution. J. Am. Chem. Soc., 1999, 121(2), 470-471.
Dai, J.; Chen, D.; Jones, R.A.; Hurley, L.H.; Yang, D. NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region. Nucleic Acids Res., 2006, 34(18), 5133-5144.
[] [PMID: 16998187]
Yi, C.; He, C. DNA repair by reversal of DNA damage. Cold Spring Harb. Perspect. Biol., 2013, 5(1) a012575
[] [PMID: 23284047]
Trott, O.; Olson, A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem., 2010, 31(2), 455-461.
[ 10.1002/jcc.21334] [PMID: 19499576]
Mihai, V. Putz, Nicoleta A. Dudaṣ. Variational principles for mechanistic quantitative structure-activity relationship (QSAR) studies: application on uracil derivates’ anti HIV action. Struct. Chem., 2013, 24(6), 1873-1893.
Putz, M.V.; Dudaş, N.A. Determining chemical reactivity driving biological activity from SMILES transformations: the bonding mechanism of anti-HIV pyrimidines. Molecules, 2013, 18(8), 9061-9116.
[] [PMID: 23903183]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy